Key terms
About DVA
DaVita, Inc. engages in the provision of medical care services. It operates through the following two segments: US Dialysis and Related Lab Services, and Other-Ancillary Services and Strategic Initiatives. The US Dialysis and Related Lab Services segment offers kidney dialysis services in the United States for patients suffering from chronic kidney failure. The Other-Ancillary Services and Strategic Initiatives segment consist primarily of pharmacy services, disease management services, vascular access services, clinical research programs, physician services, direct primary care, end stage renal disease seamless care organizations, and comprehensive care. The company was founded in 1994 and is headquartered in Denver, CO.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest DVA news
Nov 06
7:33am ET
Truist Financial Remains a Hold on DaVita (DVA)
Nov 04
4:17am ET
Barclays Remains a Hold on DaVita (DVA)
Oct 31
6:31am ET
DaVita price target raised to $164 from $150 at Barclays
Oct 31
4:40am ET
Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Organon (OGN) and DaVita (DVA)
Oct 30
7:46am ET
DaVita (DVA) Gets a Hold from TD Cowen
Oct 30
7:10am ET
Truist Financial Remains a Hold on DaVita (DVA)
Oct 30
7:10am ET
Analysts’ Opinions Are Mixed on These Healthcare Stocks: DaVita (DVA), Pfizer (PFE) and Collegium Pharmaceutical (COLL)
Oct 30
6:19am ET
DaVita Faces Operational Challenges and Volume Uncertainty: Analyst Maintains Underperform Rating
Oct 30
5:28am ET
DaVita Inc. Reports Strong Q3 2024 Performance
Oct 29
7:25pm ET
Closing Bell Movers: Alphabet up over 5% on Q3 earnings beat
Oct 29
4:14pm ET
DaVita reports Q3 adjusted EPS $2.59, consensus $2.73
Oct 29
4:12pm ET
DaVita backs FY24 adjusted EPS view $9.25-$10.05, consensus $9.79
Oct 17
1:10pm ET
DaVita appoints Jessica Hergenreter as CPO
Oct 07
7:50am ET
DaVita price target raised to $175 from $165 at Truist
Sep 13
4:48pm ET
DaVita Kidney Care Names David P. Maughan New COO
Sep 13
8:06am ET
DaVita names David Maughan as COO
Sep 13
3:17am ET
DaVita (DVA) Gets a Hold from Barclays
Aug 20
7:20am ET
Analysts Conflicted on These Healthcare Names: Autolus Therapeutics (AUTL), DaVita (DVA) and Bruker (BRKR)
Aug 20
7:19am ET
DaVita price target raised to $165 from $150 at Truist
Aug 15
6:07pm ET
DaVita exec Waters sells 7,857 common shares
Aug 09
11:15am ET
Maintain Position on DaVita: A Balanced View of Strong Performance and Future Caution
Oct 30
11:46am ET
DaVita Stock Declines After Q3 Earnings Miss Estimates, Margins Up
Oct 29
5:15pm ET
DaVita HealthCare (DVA) Q3 Earnings Miss Estimates
Oct 25
12:19pm ET
DVA Q3 Estimates Unchanged Before Earnings: How to Play the Stock?
Oct 23
6:00pm ET
DaVita HealthCare (DVA) Stock Moves -0.23%: What You Should Know
Oct 22
6:15pm ET
DaVita HealthCare (DVA) Increases Despite Market Slip: Here's What You Need to Know
Oct 21
1:29pm ET
AVTR Stock Flat Following the Close of Divestiture Deal With Audax
DVA Financials
Key terms
Ad Feedback
DVA Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
DVA Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
